Clinical Trials Directory

Trials / Completed

CompletedNCT03634566

Effect of N_Acetylcysteine on Liver Functions in Donors in Living Liver Transplantation

Effect of N_Acetylcysteine on Liver Functions in Donors in Living Donor Liver Transplantation

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

our practice for the past 10 years we have noticed a transitional impairment of liver function (elevated liver enzymes, total and direct bilirubin, and elevated serum lactate levels) following donors' liver resection. Several drugs have been investigation on liver regeneration , proven benefit of N-Acetylcysteine (NAC) on rats with steatohpatitis

Conditions

Interventions

TypeNameDescription
DRUGN-AcetylecysteineN-Acetylecysteine 150 mg/kg diluted in 100 ml glucose 5 % over 40 minutes followed by NAC 12.5 mg/kg in 500 ml glucose 5% over 4 hours, followed by NAC 6.25 mg/kg for 2 postoperative days
DRUGPlaceboRinger acetate continuous infusion at the same rate for 2 days.

Timeline

Start date
2018-04-01
Primary completion
2019-02-01
Completion
2019-04-01
First posted
2018-08-16
Last updated
2020-02-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03634566. Inclusion in this directory is not an endorsement.